Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy

Urologic Oncology: Seminars and Original Investigations

Volumn 32, Issue 2, 2014, Pages 110-116

  Fairey, Adrian S ^a   Daneshmand, Siamak ^a   Wang, Lina ^a   Schuckman, Anne ^a   Lieskovsky, Gary ^a   Djaladat, Hooman ^a   Cai, Jie ^a   Miranda, Gus ^a   Skinner, Eila C ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Bladder cancer; Micropapillary urothelial carcinoma; Radical cystectomy; Survival

Indexed keywords

CISPLATIN; DOXORUBICIN; GEMCITABINE; METHOTREXATE; VINBLASTINE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER GRADING; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CYSTECTOMY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MICROPAPILLARY UROTHELIAL CARCINOMA; MIDDLE AGED; PELVIC LYMPH NODE DISSECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA; TREATMENT DURATION; TREATMENT OUTCOME; URINARY DIVERSION; VERY ELDERLY;

BLADDER CANCER; MICROPAPILLARY UROTHELIAL CARCINOMA; RADICAL CYSTECTOMY; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; OUTCOME ASSESSMENT (HEALTH CARE); PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS;

EID: 84892529452     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2012.04.020     Document Type: Article

References (18)

1. Siegal R., Ward E., Brawley O., et al. Cancer statistics. CA Cancer J Clin 2011, 2011:212-236.
2. AJCC Cancer Staging Manual 2010, Springer, New York. 7th ed. S. Edge, D. Byrd, C. Compton (Eds.).
3. Eble J.N., Sauter G., Epstein J.I., et al. Pathology and genetic of tumours of the urinary system and male genital organs 2004, IARC (International Agency for Research on Cancer), Lyon, France.
4. Epstein J.I., Amin M.B., Reuter V.R., et al. The World Health Organization/international society of Urological pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference committee. Am J Surg Pathol 1998, 22:1435-1448.
5. Amin M.B., Ro J.Y., El-Sharkway T., et al. Micorpapillary variant of transitional cell carcinoma of the urinary bladder. Am J Surg Pathol 1994, 18:1224-1232.
6. Johansson S.L., Borghede G., Holmäng S. Micropapillary bladder carcinoma: A clinicopathologic study of 20 cases. J Urol 1999, 161:1798-1802.
7. Maranchie J.K., Bouyounes B.T., Zhang P.L., et al. Clinical and pathological characteristics of micropapillary transitional cell carcinoma: A highly aggressive variant. J Urol 1999, 163:748-751.
8. Samaratunga H., Khoo K. Micropapillary variant of urothelial carcinoma of the urinary bladder: A clinicopathologica and immunohistochemical study. Histopathology 2004, 45:55-64.
9. Alvarado-Cabrero I., Sierra-Santiesteban F.I., Mantilla-Morales A., et al. Micropapillary carcinoma of the urothelial tract: A clinicopathologic study of 38 cases. Ann Diagn Pathol 2005, 9:1-5.
10. Kamat A.M., Dinney C.P., Gee J.R., et al. Micropapillary bladder cancer: A review of the university of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients. Cancer 2007, 110:62-67.
11. Alkibay T., Sözen S., Gurocak S., et al. Micropapillary pattern in urothelial carcinoma: A clinicopathologic analysis. Urol Int 2009, 83:300-305.
12. Heudel P., El Karak F., Ismaili N., et al. Micropapillary bladder cancer: A review of the Leon Berard Cancer Center experience. BMC Urol 2009, 9:5-10.
13. Black P.C., Brown G.A., Dinney C.P. The impact of variant histology on the outcome of bladder cancer treated with curative intent. Urol Oncol 2009, 27:3-7.
14. Dorin R.P., Daneshmand S., Eisenberg M.S., et al. Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: A comparative mapping study. Eur Urol 2011, 60:946-952.
15. Stein J.P., Penson D.F., Cai J., et al. Radical cystectomy with extended lymphadenectomy: Evaluating separate package versus en bloc submission for node positive bladder cancer. J Urol 2007, 177:876-881.
16. Kunze E., Francksen B. Histogenesis of nonurothelial carcinomas of the urinary bladder from pre-existent transitional cell carcinomas: A histopathologic and immunohistochemical study. Urol Res 2002, 30:66-78.
17. Watts K.E., Hansel D.E. Emerging concepts in micropapillary urothelial carcinoma. Adv Anat Pathol 2010, 17:182-186.
18. Ghoneim I.A., Miocinovic R., Stephenson A.J., et al. Neoadjuvant systemic therapy or early cystectomy?. Single-center analysis of outcomes after therapy for patients with clinically localized micropapillary urothelial carcinoma of the bladder. Urology 2011, 77:867-870.